Inspire Medical Systems
INSP
328 hedge funds and large institutions have $6.84B invested in Inspire Medical Systems in 2024 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 124 increasing their positions, 109 reducing their positions, and 54 closing their positions.
14% more repeat investments, than reductions
Existing positions increased: 124 | Existing positions reduced: 109
8% more capital invested
Capital invested by funds: $6.35B → $6.84B (+$490M)
1.82% more ownership
Funds ownership: 105.68% → 107.5% (+1.8%)
4% less funds holding
Funds holding: 343 → 328 (-15)
18% less funds holding in top 10
Funds holding in top 10: 11 → 9 (-2)
20% less call options, than puts
Call options by funds: $130M | Put options by funds: $162M
20% less first-time investments, than exits
New positions opened: 43 | Existing positions closed: 54
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$231M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$102M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
+$65.7M |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$59M |
| 5 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$46.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SPC
Slate Path Capital
New York
|
-$59.8M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$50.4M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$44.7M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$41.3M |
| 5 |
Morgan Stanley
New York
|
-$41.3M |
INSP Hedge Fund Activity: Q1 2024 in Review
328 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Inspire Medical Systems (INSP) for Q1 2024, worth a combined $6.84B — up 7.7% from $6.35B a quarter earlier.
Sellers outnumbered buyers: 54 funds closed out of INSP and 43 opened new positions — a net loss of 11 holders — while 109 trimmed existing stakes and 124 added.
The largest buyer was Fidelity Investments, adding an estimated $231M. The largest seller was Slate Path Capital, exiting entirely with an estimated $59.8M sold.
- 328 institutional investors held Inspire Medical Systems (INSP) as of Q1 2024, down from 343 in Q4 2023.
- Funds reported $6.84B of Inspire Medical Systems stock for Q1 2024, up 7.7% quarter-over-quarter.
- 43 funds opened new Inspire Medical Systems positions in Q1 2024 and 54 closed out, a net change of -11 holders.
- The largest Inspire Medical Systems buyer in Q1 2024 was Fidelity Investments, an estimated $231M added.
- The largest Inspire Medical Systems seller in Q1 2024 was Slate Path Capital, an estimated $59.8M sold.
Based on aggregated 13F filings for Q1 2024.